Elizabeth Young

Elizabeth joined ACF Investors as a Senior Investment Analyst in August 2021 where she is primarily responsible for sourcing deal flow for the £100m Angel CoFund and Delta Fund.

She has an extensive background in medical engineering, having completed her BSc Hons in Molecular and Cellular Biology (with Biotechnology) at the University of Glasgow. Her interest in neural plasticity in response to inflammation and the resulting impact on cognitive health, combined with an interest in tissue engineering, led her to a PhD in modelling the pathology of vascular injury during non-traumatic spinal cord compression from the University of Leeds, during which she was a crucial part of growing Creator Fund's footprint in the North of England.